134 related articles for article (PubMed ID: 14551048)
1. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.
Shuralyova I; Tajmir P; Bilan PJ; Sweeney G; Coe IR
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H627-32. PubMed ID: 14551048
[TBL] [Abstract][Full Text] [Related]
2. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes.
Chaudary N; Shuralyova I; Liron T; Sweeney G; Coe IR
Biochem Cell Biol; 2002; 80(5):655-65. PubMed ID: 12440705
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
Plagemann PG; Kraupp M
Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
[TBL] [Abstract][Full Text] [Related]
5. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
6. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
Plagemann PG; Woffendin C
Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.
Keil GJ; Delander GE
J Pharmacol Exp Ther; 1995 Sep; 274(3):1387-92. PubMed ID: 7562512
[TBL] [Abstract][Full Text] [Related]
8. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
Endres CJ; Sengupta DJ; Unadkat JD
Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis.
Jiménez A; Pubill D; Pallàs M; Camins A; Lladó S; Camarasa J; Escubedo E
Eur J Pharmacol; 2000 Jun; 398(1):31-9. PubMed ID: 10856445
[TBL] [Abstract][Full Text] [Related]
10. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
Kalsi KK; Smolenski RT; Yacoub MH
Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
[TBL] [Abstract][Full Text] [Related]
11. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE
J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
13. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
14. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
15. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
Plagemann PG
J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
[TBL] [Abstract][Full Text] [Related]
17. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
Gu JG; Nath A; Geiger JD
J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of insulin-stimulated glucose transport in rat adipocytes by nucleoside transport inhibitors.
Steinfelder HJ; Joost HG
FEBS Lett; 1988 Jan; 227(2):215-9. PubMed ID: 3276559
[TBL] [Abstract][Full Text] [Related]
19. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides.
Dagnino L; Paterson AR
Cancer Res; 1990 Oct; 50(20):6549-53. PubMed ID: 1698538
[TBL] [Abstract][Full Text] [Related]
20. Selective transport of adenosine into porcine coronary smooth muscle.
Rubin LJ; Johnson LR; Dodam JR; Dhalla AK; Magliola L; Laughlin MH; Jones AW
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1397-410. PubMed ID: 10993808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
